Bicycle Therapeutics Clears Debt Early, Strengthens Finances
Company Announcements

Bicycle Therapeutics Clears Debt Early, Strengthens Finances

An update from Bicycle Therapeutics (BCYC) is now available.

Bicycle Therapeutics plc has fully repaid its $30.0 million debt to Hercules Capital, Inc. ahead of its 2025 maturity date, settling the loan with a $31.9 million payment from its cash reserves. This strategic financial move releases the company from the annual interest rates between 8.05% and 9.05%, and also frees its assets from previously granted security interests. This bold step could signify a strong cash position or shift in fiscal strategy for Bicycle Therapeutics.

Learn more about BCYC stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyMolson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
TheFlyBicycle Therapeutics initiated with an Equal Weight at Stephens
TheFlyStephens sees ‘uphill battle’ for Bicycle Therapeutics, starts at Equal Weight
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App